Envision Pharma Group

Big news from our 90TEN team!    This recognition highlights the power of impactful healthcare communications and the dedication of our colleagues to driving meaningful conversations around prostate cancer. Huge congratulations to the 90TEN team and our partners for this achievement – an outstanding example of purpose-driven engagement in action. #PRMomentAwards #HealthcareComms #LifeSciences #ProstateCancer

At Envision Pharma Group, we’re making a measurable impact with bold commitments to reduce our carbon footprint and promote sustainable practices across our operations and supply chain. Here’s how we’re turning commitment into action: - 55% reduction in Scope 1 and 2 greenhouse gas (GHG) emissions by 2030 from a 2022 base year - 52% reduction in Scope 3 GHG emissions from business travel per full-time employee by 2030 from a 2023 base year - 75% of suppliers to have science-based targets by 2028 These goals represent more than just numbers – they reflect our mission to create smarter outcomes for life sciences and a healthier future for our planet. Explore our latest sustainability initiatives in the carousel images to learn more.

Get ready to experience the future of medical affairs technology at Envision Accelerate US 2025 – happening May 1 in Philadelphia! - Explore fresh topics tackling today’s biggest industry challenges - Dive into technology tracks showcasing the latest innovations - Experience a live demo of EnvisionOne, our next-generation platform driving medical affairs excellence Whether you're seeking new insights or hands-on experience with transformative technology, this event is for you. Reserve your spot now: https://lnkd.in/g6nr3JX8. 

In today’s data-saturated healthcare landscape, healthcare professionals and patients face an overwhelming amount of fragmented, complex information. At Envision Medical Communications (EMC), we bridge this gap by blending technology with over 20 years of medcomms expertise to deliver clear, impactful solutions that drive better outcomes. Here’s how we do it: - Data-driven storytelling – Turning complex science into compelling, visual narratives - Omnichannel engagement – Creating tailored experiences through personalized, AI-powered content - Combined intelligence – Pairing cutting-edge technology with deep human insight to solve real-world challenges At EMC, innovation is guided by one core principle: client-centricity. We listen closely, collaborate deeply, and craft solutions that exceed expectations. Learn more here: https://bit.ly/4gL29d6 #MedicalCommunications #AI #ClientCentricity #EMC

Keeping up with market trends and making smarter decisions is essential in life sciences. That’s why EnvisionOne Vantage is here to help medical affairs teams turn data into clear, strategic insights. Through combining industry benchmarks and advanced analytics, this platform enables you to sharpen your publication strategies with precision, identify and engage key opinion leaders more effectively, and make data-driven decisions to accelerate research impact and spot market trends. Backed with over 20 years of historical intelligence and AI capabilities, EnvisionOne Vantage turns complex data into strategies that provide that competitive advantage. See how it can elevate your medical affairs approach. 👉 https://bit.ly/3EiZ3zR #EnvisionOneVantage #MedicalAffairs #LifeSciences #AI #Data

From AI-written content to tackling misinformation, the way we share scientific information is changing fast. But which trend will have the biggest impact in med comms in 2025? Vote in the poll and tell us why in the comments! #MedComms #AIinPharma #HealthLiteracy #HCPEngagement

How well do you know your competitive landscape? EnvisionOne Vantage is the only benchmarking software tailored specifically for life sciences companies. It’s the latest solution for our next-generation #EnvisionOne platform. What makes it a game-changer? - Unmatched industry benchmarking: Access real-time, anonymized data to compare your performance against competitors - Data-driven insights: Make informed decisions with comprehensive analytics and intuitive visualizations that turn complex data into actionable strategies - Exclusivity: The only industry expert with access to exclusive industry data that allows your team to focus on high-impact activities As part of the EnvisionOne platform, Vantage integrates seamlessly with iEnvision and Classic, empowering you to elevate your medical affairs strategies. Discover how EnvisionOne Vantage can benefit your organization: 👉 https://bit.ly/3EiZ3zR #EnvisionOneVantage #MedicalAffairs #LifeSciences #AI #Data

Introducing EnvisionOne Vantage, the latest solution for our next-generation #EnvisionOne platform. This remarkable tool enables life sciences companies to optimize their publication strategies through data-driven insights. Fashioned from decades of industry intelligence, its key benefits include benchmarking publication performance, identifying areas for improvement, and really helping users to engage key opinion leaders. Not only that, but coming this year AI-powered predictive analytics will also be available to facilitate smarter forecasting and resource allocation – and even anticipate patient responses to engagement efforts. As our Chief Technology Officer, Jim Streeter, notes: “At a time of escalating costs and increasing workflow complexities, the release of this solution ahead of the highly anticipated EnvisionOne platform is a real game changer.” Read more about how EnvisionOne Vantage is going to help shape the future of medical affairs: 👉 https://bit.ly/40KPv84 #EnvisionOneVantage #MedicalAffairs #LifeSciences #AI #Data

We’re thrilled to host the return of the Envision Accelerate US meeting for 2025! Save the date and plan to join us on May 1 in Philadelphia. This event shines a light on how the power of technology can accelerate the impact of bringing life-changing treatment to patients. Experience next-generation industry software designed to level up the contributions of your medical affairs teams. Are you ready to commit to a tech-enhanced, data-driven future? For more event information and to register today, visit: https://lnkd.in/g6nr3JX8. #Accelerate #Technology #Envision #Innovation

Great insight from our team as #ISMPPEurope 2025 comes to an end. It's fascinating to think about how AI is changing medical publishing. Our colleague Mary Gaskarth, CMPP shared some thoughts after the closing session on whether AI will make medical publishing professionals obsolete by 2035. The consensus? While AI is clearly a game-changer that helps us analyze, review, and communicate information faster and in new ways, the human element is still so essential. Things like nuanced interpretation, crafting compelling narratives, and ensuring inclusive communication – those are uniquely human skills. Sounds like it was a really engaging discussion, and we're excited to see how our industry evolves. Big thanks to the organizers for putting together such a valuable event. #AI #MedComms #ISMPP #Publishing